SCHEMBL1180781

SCHEMBL1180781

COc1ccc(-c2ccc(-c3cccc(OC)c3)s2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 6/20 0.74
▸ CYP1A1 P04798 1/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ CYP2E1 P05181 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ CYP2C8 P10632 1/20 0.60
▸ CYP2D6 P10635 1/20 0.60
▸ CYP2A6 P11509 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ CYP4B1 P13584 1/20 0.60
▸ CYP2B6 P20813 1/20 0.60
▸ CYP3A5 P20815 1/20 0.60
▸ CYP2A7 P20853 1/20 0.60
▸ CYP3A7 P24462 1/20 0.60
▸ CYP2F1 P24903 1/20 0.60
▸ CYP2C18 P33260 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ CYP2J2 P51589 1/20 0.60
▸ CYP4F2 P78329 1/20 0.60
▸ CYP4F8 P98187 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1181635 0.94 CYP1A1 (0.67) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL11522028 0.86 APP (0.83) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL1181273 0.86 APP (1.00) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL13446070 0.84 APP (0.95) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL14705443 0.84 APP (0.95) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL147295 0.84 HDAC6 (0.56) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL25094618 0.82 HDAC6 (0.55) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL9430000 0.82 HDAC6 (0.55) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL12093643 0.82 HDAC6 (0.55) APPCYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL1180412 0.82 ABL1 (0.77) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046147-A1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES UNIVERSITAT DES SAARLANDES (DE) 2011-02-24 — — US disclosed
US-20110046147-A1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES UNIVERSITAT DES SAARLANDES (DE) 2011-02-24 — — US disclosed
US-20110046147-A1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES UNIVERSITAT DES SAARLANDES (DE) 2011-02-24 — — US disclosed
EP-2190421-A2 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2010-06-02 — — EP disclosed
WO-2009027346-A2 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2009-03-05 — — WO disclosed
WO-2009027346-A2 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-DEPENDENT DISEASES Universität des Saarlandes (DE) 2009-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046147-A1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES HSD17B1, HSD17B11, HSD17B2 APP 2623/4885CYP1A1 113/4885CYP1A2 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback